Mark A. Boerneke

1.1k total citations
18 papers, 665 citations indexed

About

Mark A. Boerneke is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Mark A. Boerneke has authored 18 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Infectious Diseases. Recurrent topics in Mark A. Boerneke's work include RNA and protein synthesis mechanisms (14 papers), RNA modifications and cancer (9 papers) and Viral Infections and Immunology Research (7 papers). Mark A. Boerneke is often cited by papers focused on RNA and protein synthesis mechanisms (14 papers), RNA modifications and cancer (9 papers) and Viral Infections and Immunology Research (7 papers). Mark A. Boerneke collaborates with scholars based in United States, India and South Africa. Mark A. Boerneke's co-authors include Thomas Hermann, Kevin M. Weeks, Sergey M. Dibrov, Olga G. Troyanskaya, Christine Roden, Joanne Ekena, Rachel Sealfon, Christiane Iserman, Grace A. McLaughlin and Amy S. Gladfelter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Mark A. Boerneke

18 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Boerneke United States 11 497 151 118 89 60 18 665
Valérie Vivet‐Boudou France 13 370 0.7× 192 1.3× 62 0.5× 58 0.7× 38 0.6× 27 595
Wahyu Surya Singapore 14 328 0.7× 311 2.1× 39 0.3× 53 0.6× 42 0.7× 35 641
Joshua D. Jones United States 11 603 1.2× 123 0.8× 77 0.7× 30 0.3× 30 0.5× 18 761
Nathan A. Siegfried United States 11 939 1.9× 58 0.4× 57 0.5× 56 0.6× 17 0.3× 17 1.0k
Chung-Cheng Liu Taiwan 9 560 1.1× 65 0.4× 44 0.4× 110 1.2× 59 1.0× 10 747
Takuya Umehara Japan 15 951 1.9× 53 0.4× 32 0.3× 50 0.6× 44 0.7× 32 1.1k
Frédéric Garzoni France 13 671 1.4× 274 1.8× 26 0.2× 46 0.5× 63 1.1× 21 966
Denis Bouvier France 11 529 1.1× 222 1.5× 117 1.0× 38 0.4× 222 3.7× 16 1.0k
Vidya Dhote United States 9 694 1.4× 76 0.5× 215 1.8× 32 0.4× 27 0.5× 11 834

Countries citing papers authored by Mark A. Boerneke

Since Specialization
Citations

This map shows the geographic impact of Mark A. Boerneke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Boerneke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Boerneke more than expected).

Fields of papers citing papers by Mark A. Boerneke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Boerneke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Boerneke. The network helps show where Mark A. Boerneke may publish in the future.

Co-authorship network of co-authors of Mark A. Boerneke

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Boerneke. A scholar is included among the top collaborators of Mark A. Boerneke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Boerneke. Mark A. Boerneke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Boerneke, Mark A., Nandan S. Gokhale, Stacy M. Horner, & Kevin M. Weeks. (2023). Structure-first identification of RNA elements that regulate dengue virus genome architecture and replication. Proceedings of the National Academy of Sciences. 120(15). e2217053120–e2217053120. 12 indexed citations
2.
Roden, Christine, Yifan Dai, Ian Seim, et al.. (2022). Double-stranded RNA drives SARS-CoV-2 nucleocapsid protein to undergo phase separation at specific temperatures. Nucleic Acids Research. 50(14). 8168–8192. 51 indexed citations
3.
Boerneke, Mark A., et al.. (2020). Syntheses and Binding Testing of N1-Alkylamino-Substituted 2-Aminobenzimidazole Analogues Targeting the Hepatitis C Virus Internal Ribosome Entry Site*. Australian Journal of Chemistry. 73(3). 212–221. 5 indexed citations
4.
Iserman, Christiane, Christine Roden, Mark A. Boerneke, et al.. (2020). Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid. Molecular Cell. 80(6). 1078–1091.e6. 240 indexed citations
5.
Boerneke, Mark A., et al.. (2019). Physical and Functional Analysis of Viral RNA Genomes by SHAPE. Annual Review of Virology. 6(1). 93–117. 45 indexed citations
6.
Dethoff, Elizabeth A., Mark A. Boerneke, Nandan S. Gokhale, et al.. (2018). Pervasive tertiary structure in the dengue virus RNA genome. Proceedings of the National Academy of Sciences. 115(45). 11513–11518. 77 indexed citations
7.
Boerneke, Mark A. & Kevin M. Weeks. (2018). High-Throughput Explorations of RNA Structural Modularity. Biochemistry. 57(43). 6129–6131. 1 indexed citations
8.
Nuthanakanti, Ashok, Mark A. Boerneke, Thomas Hermann, & Seergazhi G. Srivatsan. (2017). Structure of the Ribosomal RNA Decoding Site Containing a Selenium‐Modified Responsive Fluorescent Ribonucleoside Probe. Angewandte Chemie. 129(10). 2684–2688. 5 indexed citations
9.
Boerneke, Mark A. & Thomas Hermann. (2017). Design and Crystallography of Self-Assembling RNA Nanostructures. Methods in molecular biology. 1632. 135–149. 3 indexed citations
10.
Nuthanakanti, Ashok, Mark A. Boerneke, Thomas Hermann, & Seergazhi G. Srivatsan. (2017). Structure of the Ribosomal RNA Decoding Site Containing a Selenium‐Modified Responsive Fluorescent Ribonucleoside Probe. Angewandte Chemie International Edition. 56(10). 2640–2644. 26 indexed citations
11.
Boerneke, Mark A.. (2016). Ligand-responsive RNA switches: viral translation regulators, therapeutic targets, and tunable building blocks for nanotechnology. eScholarship (California Digital Library). 1 indexed citations
12.
Boerneke, Mark A., Sergey M. Dibrov, & Thomas Hermann. (2016). Crystal‐Structure‐Guided Design of Self‐Assembling RNA Nanotriangles. Angewandte Chemie International Edition. 55(12). 4097–4100. 38 indexed citations
13.
Boerneke, Mark A. & Thomas Hermann. (2015). Ligand-responsive RNA mechanical switches. RNA Biology. 12(8). 780–786. 8 indexed citations
14.
Boerneke, Mark A. & Thomas Hermann. (2015). Conformational flexibility of viral RNA switches studied by FRET. Methods. 91. 35–39. 8 indexed citations
15.
Rynearson, Kevin D., et al.. (2014). 2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site. Bioorganic & Medicinal Chemistry Letters. 24(15). 3521–3525. 23 indexed citations
16.
Wang, Annie, et al.. (2014). Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site. Bioorganic & Medicinal Chemistry Letters. 24(14). 3113–3117. 22 indexed citations
17.
Boerneke, Mark A., Sergey M. Dibrov, Jing Gu, David Wyles, & Thomas Hermann. (2014). Functional conservation despite structural divergence in ligand-responsive RNA switches. Proceedings of the National Academy of Sciences. 111(45). 15952–15957. 38 indexed citations
18.
Dibrov, Sergey M., Jerod Parsons, Maia Carnevali, et al.. (2013). Hepatitis C Virus Translation Inhibitors Targeting the Internal Ribosomal Entry Site. Journal of Medicinal Chemistry. 57(5). 1694–1707. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026